Return to List

First Author




PubMed Link

Justinova Z et al. Differential Effects of Presynaptic versus Postsynaptic Adenosine A2A Receptor Blockade on Δ9-Tetrahydrocannabinol (THC) Self-Administration in Squirrel Monkeys. Journal of Neuroscience 2014/05/07 24806674
Mijangos-Moreno S, Poot-Ake A et al. Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. Neuroscience Research 2014/05/04 24800644
Fujii M et al. Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats. Journal of Neurological Sciences 2014/04/30 24819918
Lee JL and Flavell CR Inhibition and enhancement of contextual fear memory destabilization. Frontiers in Behavioural Neuroscience 2014/04/28 24808841
Al Kury LT et al. Effects of endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. British Journal of Pharmacology 2014/04/24 24758718
Battostella et al. Long-Term Effects of Cannabis on Brain Structure. Neuropsychopharmacology 2014/03/17 24633558
Silvani, Berteotti, Bastianini, Lo Martire et al. Multiple sleep alterations in mice lacking cannabinoid type 1 receptors. PLoS One 2014/02/20 24586776
Jones NA, et al. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure. 2012/04/08 22520455
Giuffrida A, Seillier A. New insights on endocannabinoid transmission in psychomotor disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2012/04/10 22521335
Wilson-Poe AR, et al. Distribution of CB1 Cannabinoid Receptors and Their Relationship with Mu-Opioid Receptors in the Rat Periaqueductal Gray. Neuroscience. 2012/04/18 22521830
Katona I, Freund TF. Multiple Functions of Endocannabinoid Signaling in the Brain. Annu Rev Neurosci. 2012/04/17 22524785
Taffe MA. {Delta}9tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques. J Psychopharmacol. 2012/04/22 22526684
Callen L, et al. Cannabinoid receptors CB1 and CB2 form functional heteromers in the brain. J Biol Chem. 2012/04/24 22532560
Wu HY, et al. Cannabidiol-induced apoptosis in murine microglial cells through lipid raft. Glia. 2012/04/25 22535572
Haghani M, et al. CB1 Cannabinoid Receptor Activation Rescues Amyloid β-Induced Alterations in Behaviour and Intrinsic Electrophysiological Properties of Rat Hippocampal CA1 Pyramidal Neurones. Cell Physiol Biochem. 2012/04/03 22508047
Sayers KW, et al. Statistical parametric mapping reveals regional alterations in cannabinoid CB(1) receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain. Epilepsia. 2012/05/00 22509801
Zarrindast MR, et al. The amnesic effect of intra-central amygdala administration of a cannabinoid CB1 receptor agonist, WIN55,212-2, is mediated by a beta-1 noradrenergic system in rat. Neuroscience. 2012/04/16 22516010
Song J, et al. Gating the polarity of endocannabinoid-mediated synaptic plasticity by nitric oxide in the spinal locomotor network. J Neurosci. 2012/04/11 22496555
Xiong W, et al. A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors. J Neurosci. 2012/04/11 22496565
Rogers RC, Hermann GE. Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J Neurosci. 2012/04/11 22496569
Wu X, et al. Alteration of endocannabinoid system in human gliomas. J Neurochem. 2012/03/00 22176552
Ramot A, Akirav I. Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience. Neurobiol Learn Mem. 2012/03/16 22445897
Min R, Nevian T. Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci. 2012/03/16 22446881
Karl T, et al. The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opin Ther Targets. 2012/03/27 22448595
Aso E, et al. CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice. J Alzheimers Dis. 2012/03/26 22451318
Ievglevskyi O, et al. Modulation of ATP-induced LTP by cannabinoid receptors in rat hippocampus. Purinergic Signal. 2012/03/28 22453905
Campolongo P, et al. The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci. 2012/03/20 22454620
Kallendrusch S, et al. Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections. PLoS One. 2012/03/22 22457773
Wilkerson JL, et al. Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain. 2012/03/16 22425445
Kleijn J, et al. Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation. Neurochem Int. 2012/03/10 22426202
Bowers ME, et al. Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y. Physiol Behav. 2012/03/10 22429904
Kim DJ, et al. Structural Network Topology Revealed by White Matter Tractography in Cannabis Users: A Graph Theoretical Analysis. Brain Connect. 2012/02/12 22432904
Dubreucq S, et al. Genetic Dissection of the Role of Cannabinoid Type-1 Receptors in the Emotional Consequences of Repeated Social Stress in Mice. Neuropsychopharmacology. 2012/03/21 22434220
Weston-Green K, et al. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain. PLoS One. 2012/03/16 22438946
Ramirez SH, et al. Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions. J Neurosci. 2012/03/21 22442067
Jung KM, et al. 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab. 2012/03/07 22405068
Scuderi C, et al. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor- alpha. J Neuroinflammation. 2012/03/09 22405189
Laricchiuta D, et al. Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission. PLoS One. 2012/03/08 22413007
Van Waes V, et al. CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation. Front Pharmacol. 2012/03/12 22416230
Cornélio AM, et al. Contribution of the rostral ventromedial medulla to post-anxiety induced hyperalgesia. Brain Res. 2012/02/22 22418057
Farkas S, et al. The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist [(125)I]SD7015. Brain Res Bull. 2012/03/07 22421165
Han J, et al. Acute Cannabinoids Impair Working Memory through Astroglial CB(1) Receptor Modulation of Hippocampal LTD. Cell. 2012/03/07 22385967
Bénard G, et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci. 2012/03/04 22388959
Messer RD, Levine ES. Epileptiform activity in the CA1 region of the hippocampus becomes refractory to attenuation by cannabinoids in part because of endogenous γ-aminobutyric acid type B receptor activity. J Neurosci Res. 2012/03/02 22388975
Polissidis A, et al. The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. Int J Neuropsychopharmacol. 2012/03/06 22391102
Bosier B, et al. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo. Neuropharmacology. 2012/02/13 22365976
Pacher P, Mackie K. Interplay of cannabinoid 2 (CB(2)) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration. J Mol Med (Berl). 2012/02/28 22371074
Abush H, Akirav I. . Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One. 2012/02/13 22348124
Klumpers F, et al. Testing the effects of {Delta}9-THC and D-cycloserine on extinction of conditioned fear in humans. J Psychopharmacol. 2012/02/20 22351380
den Boon FS, et al. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci U S A. 2012/02/13 22331871
Trifonov S, et al. Lateral regions of the rodent striatum reveal elevated glutamate decarboxylase 1 mRNA expression in medium-sized projection neurons. Eur J Neurosci. 2012/02/15 22332935
D'Souza DC, et al. Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans. Neuropsychopharmacology. 2012/02/15 22334121
Gruber SA, et al. Age of onset of marijuana use impacts inhibitory processing. Neurosci Lett. 2012/01/15 22306089
Hassanzadeh P, Hassanzadeh A. The CB(1) Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin. Neurochem Res. 2012/02/07 22311129
Antonucci F, et al. Cracking Down on Inhibition: Selective Removal of GABAergic Interneurons from Hippocampal Networks. J Neurosci. 2012/02/08 22323713
Fernández-López D, et al. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke. Neuroscience. 2012/01/12 22285309
Sideris A, et al. A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion. Front Neurosci. 2012/01/24 22291615
Sun Y, et al. Cannabinoid Receptor Activation Disrupts the Internal Structure of Hippocampal Sharp Wave-Ripple Complexes. J Pharmacol Sci. 2012/02/01 22293299
El Khoury MA, et al. Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies. Prog Neuropsychopharmacol Biol Psychiatry. 2012/01/20 22300746
Fitzgerald ML, et al. Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output. Prog Neuropsychopharmacol Biol Psychiatry. 2012/01/12 22265889
Naidoo V, et al. Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology. Neurotherapeutics. 2012/01/20 22270809
Rojo ML, et al. Lysophosphatidylinositol Stimulates [(35)S]GTPγS Binding in the Rat Prefrontal Cortex and Hippocampus. Neurochem Res. 2012/01/22 22270908
Sagredo O, et al. Cannabinoids: Novel Medicines for the Treatment of Huntington's Disease. Recent Pat CNS Drug Discov. 2012/04/01 22280340
Puente N, et al. Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci. 2011/11/16 22057189
Fisone G, et al. Molecular mechanisms of l-DOPA-induced dyskinesia. Int Rev Neurobiol. 2011/09/08 21907084
Higuera-Matas A, et al. Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure. Neuropharmacology. 2012/01/08 22245681
Marchalant Y, et al. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? J Neuroinflammation. 2012/01/16 22248015
Martin Moreno AM, et al. Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice. J Neuroinflammation. 2012/01/16 22248049
Farkas S, et al. [(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease. Neurochem Int. 2011/12/28 22222721
Breen C, et al. The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain. Neurosci Lett. 2011/12/31 22227298
Chi DH, Kandler K. Cannabinoid receptor expression at the MNTB-LSO synapse in developing rats. Neurosci Lett. 2011/12/31 22230885
Nazzaro C, et al. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat Neurosci. 2012/01/08 22231426
Häring M, et al. Neuronal populations mediating the effects of endocannabinoids on stress and emotionality. Neuroscience. 2012/01/02 22233782
Carroll CB, et al. Δ(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. Neuropathol Appl Neurobiol. 2012/01/11 22236282
Verrico CD, et al. Delay- and Dose-Dependent Effects of Δ(9)-Tetrahydrocannabinol Administration on Spatial and Object Working Memory Tasks in Adolescent Rhesus Monkeys. Neuropsychopharmacology. 2012/01/04 22218091
Brownjohn PW, Ashton JC. Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury. Neuroscience. 2011/12/22 22210507
Chiodi V, et al. Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. Neurobiol Dis. 2011/12/23 22207189
Moreno-Martet M, et al. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: Relevance for in vitro studies with cannabinoids in motor neuron diseases. Neurosci Lett. 2011/12/22 22206832
Naderi N, et al. The Interaction Between Intrathecal Administration of Low Doses of Palmitoylethanolamide and AM251 in Formalin-Induced Pain Related Behavior and Spinal Cord IL1-β Expression in Rats. Neurochem Res. 2011/12/27 22201038
Martinez A, et al. The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neurosci Res. 2011/12/17 22192465
Verdurand M, et al. Comparison of Cannabinoid CB(1) Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [F]MK-9470. Int J Mol Imaging. 2011/12/11 22187642